[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 17, Issue 1 (Bimonthly 2013) ::
Feyz 2013, 17(1): 100-113 Back to browse issues page
Dendritic cell subsets biology and application in cancer immunotherapy
Mirza Ali Mofazzal-Jahromi , Sayyed Mohammad Moazzeni
Tarbiat Modares University , moazzeni@modares.ac.ir
Abstract:   (7390 Views)

Background: Cancer as the uncontrolled proliferation and spread of transformed cells is one of the leading causes of mortality in the world. Dendritic cells (DCs) can be used in cancer immunotherapy. Tumor antigen-loaded DCs are able to enhance the cytotoxic T cells (CTLs) antitumor activity.

Materials and Methods: Related articles were searched by search engines in NCBI database. Then the original and review articles were retrieved from the Science Direct, Nature, Wiley-Blackwell, Springer and ProQuest databases.

Results: The DC subsets with various functions have been identified in different tissues of both the animal model (mouse) and human. Human myeloid DC subsets could be derived from blood monocytes using the cytokine enriched media. Mouse conventional CD8+ DCs can be isolated from the spleen or derived from the bone marrow stem cells using the cytokine- enriched media.

Conclusion: Some of the human and mouse DC subsets, including human myeloid DCs and mouse conventional CD8+ DCs play a pivotal role in an induction of TH1 cells and CTLs. Therefore, these subsets can be utilized as cellular immunity stimulants in human and mouse model for cancer immunotherapy.

Keywords: Dendritic cell subsets, Cytotoxic T cells, Cancer, Immunotherapy
Full-Text [PDF 367 kb]   (8981 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2013/03/10 | Revised: 2014/06/1 | Accepted: 2013/03/17 | Published: 2013/03/17
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mofazzal-Jahromi M A, Moazzeni S M. Dendritic cell subsets biology and application in cancer immunotherapy. Feyz 2013; 17 (1) :100-113
URL: http://feyz.kaums.ac.ir/article-1-1873-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 17, Issue 1 (Bimonthly 2013) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645